Breast cancer patients may be spared chemotherapy thanks to new tests . 
 Tests pinpoint genetic 'markers' in tumour and determine aggressiveness . 
 They are available privately for Â£2,500 and may be rolled out soon on NHS . 
 Women told within days whether they have a high  risk of disease returning . 
 